Creating new HIV vaccines using advanced delivery systems
Design and Engineering of VesiVax HIV Immunogen Formulations
This study is working on new HIV vaccines that use tiny particles to help your immune system recognize and fight the virus better, so you could get a stronger and more effective vaccine in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Molecular Express, INC. NIH-funded |
| Lab location | 1 site (Rancho Dominguez, United States) |
| Project ID | NIH-11172342 on NIH RePORTER |
What this research studies
This research focuses on developing innovative HIV vaccines that utilize particle-based delivery systems to enhance immune responses. By engineering specific HIV proteins and optimizing how they are presented to the immune system, the study aims to improve the effectiveness of vaccines in generating strong antibody responses. The approach involves using lipid- and polymer-based nanoparticles to deliver these immunogens, which may lead to better protection against HIV. Patients may benefit from a more effective vaccine that could provide broader immunity against the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection who are seeking preventive measures.
Not a fit: Patients who are already living with HIV or those who are not at risk for HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a more effective HIV vaccine that provides better protection against the virus.
How similar studies have performed: Previous research has shown promise in using nanoparticle-based delivery systems for vaccines, indicating potential success for this novel approach.
Where this research is happening
Rancho Dominguez, United States
- Molecular Express, INC. — Rancho Dominguez, United States (Active)
Researchers
- Principal investigator: Ho, Samon — Molecular Express, INC.
- Study coordinator: Ho, Samon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.